Neurology · Neuromuscular Junction Disorders

Myasthenia Gravis

USMLE2PANCE
7

Bets

The facts most likely to be tested

Press 1–5 to rate · ↑↓ to navigate

1

Myasthenia gravis is caused by autoantibodies against postsynaptic acetylcholine receptors (AChR) at the neuromuscular junction.

Confidence:
2

Patients classically present with fluctuating skeletal muscle weakness and fatigability that worsens with repetitive use and improves with rest.

Confidence:
3

Ocular symptoms including ptosis and diplopia are the most common initial clinical manifestations.

Confidence:
4

The edrophonium (Tensilon) test or ice pack test can be used for rapid bedside clinical assessment of ptosis improvement.

Confidence:
5

The first-line diagnostic test is the measurement of serum anti-AChR antibodies.

Confidence:
6

Repetitive nerve stimulation or single-fiber electromyography (EMG) demonstrates a characteristic decremental response in muscle action potential amplitude.

Confidence:
7

All patients with a new diagnosis of myasthenia gravis require a CT or MRI of the chest to screen for an associated thymoma.

Confidence:

Vignette unlocked

A 32-year-old woman presents with a three-month history of progressive bilateral ptosis and diplopia that is significantly worse in the evening. She reports difficulty chewing tough foods and occasional nasal regurgitation of liquids. Physical examination reveals bilateral ptosis that improves after applying an ice pack to the eyelids for two minutes. Her strength is 4/5 in proximal muscle groups but improves after a period of rest.

What is the most appropriate next step in the diagnostic evaluation of this patient?

+Reveal answer

Serum anti-acetylcholine receptor (AChR) antibody testing

The patient's presentation of fluctuating ocular and bulbar weakness is classic for myasthenia gravis, and the initial diagnostic step is serologic testing for anti-AChR antibodies.

Mo

Depth

Full handout

High yield triage

Etiology / Epidemiology

Autoimmune destruction of postsynaptic acetylcholine receptors; bimodal distribution in young women and older men.

Clinical Manifestations

Fatigable muscle weakness worsening with use; ptosis and diplopia are classic initial findings.

Diagnosis

AChR-Ab is the most specific test; Ice pack test is a rapid bedside diagnostic tool.

Treatment

Pyridostigmine is first-line; avoid aminoglycosides which exacerbate weakness.

Prognosis

Risk of myasthenic crisis requiring mechanical ventilation; associated with thymoma in 10-15% of cases.

Full handout

Epidemiology & Etiology

Bimodal distribution: peak in women <40 and men >60. Strongly associated with thymic hyperplasia or thymoma. Often co-occurs with other autoimmune conditions like Graves disease.

Pertinent Anatomy

The neuromuscular junction is the primary site of pathology. The postsynaptic membrane contains the target receptors for autoantibodies, leading to a reduction in functional receptor density.

Pathophysiology

Autoantibodies (usually anti-AChR) bind to postsynaptic receptors, causing complement-mediated destruction. This reduces the number of available receptors, preventing the generation of an end-plate potential. Clinical weakness occurs when the safety factor for neuromuscular transmission is exceeded during repetitive activity.

Clinical Manifestations

Patients present with fluctuating weakness that improves with rest. Ocular symptoms like ptosis and diplopia are present in 85% of patients. Respiratory failure is the most feared complication during a myasthenic crisis. Bulbar symptoms include dysphagia and nasal speech.

Diagnosis

The AChR-Ab (acetylcholine receptor antibody) test is the gold standard for confirmation. The Ice pack test is highly sensitive for ocular MG, showing improvement in ptosis after 2 minutes. Electromyography (EMG) with repetitive nerve stimulation shows a characteristic decremental response.

Treatment

Pyridostigmine is the first-line symptomatic treatment. Thymectomy is indicated for all patients with a thymoma or generalized MG under age 60. Avoid aminoglycosides, fluoroquinolones, and beta-blockers as they can trigger a crisis.

Prognosis

Most patients achieve a near-normal life expectancy with immunosuppressive therapy (prednisone, azathioprine). Myasthenic crisis is a medical emergency requiring plasmapheresis or IVIG for rapid stabilization.

Differential Diagnosis

Lambert-Eaton: weakness improves with repetitive use

Botulism: descending paralysis with fixed dilated pupils

Multiple Sclerosis: upper motor neuron signs and sensory deficits

Thyroid Eye Disease: proptosis and lid retraction

Brainstem Stroke: acute onset with associated cranial nerve deficits

Myasthenia Gravis — USMLE2 / PANCE Board Prep | MoBets